[1]
2025. COST-EFFECTIVENESS ANALYSIS OF USING METFORMIN AND GLIMEPIRIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN YOGYAKARTA, INDONESIA. The Southeast Asian Journal of Tropical Medicine and Public Health. 55, Suppl 1 (Jul. 2025), 107–122.